Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Cipla Ltd ( (IN:CIPLA) ).
Cipla Ltd has been assigned an Environmental, Social, and Governance (ESG) rating of 66 for the fiscal year 2024-25 by NSE Sustainability Ratings & Analytics Limited, a SEBI registered ESG Rating Provider. This rating reflects Cipla’s commitment to sustainable practices and could enhance its reputation and attractiveness to investors focused on ESG criteria.
More about Cipla Ltd
Cipla Ltd is a prominent player in the pharmaceutical industry, primarily engaged in the development, manufacturing, and distribution of a wide range of pharmaceutical products. The company focuses on providing affordable and high-quality medicines across various therapeutic areas, serving both domestic and international markets.
Average Trading Volume: 73,101
Technical Sentiment Signal: Buy
Current Market Cap: 1209.6B INR
For an in-depth examination of CIPLA stock, go to TipRanks’ Overview page.